According to the latest report by India Ratings and Research (Ind-Ra), the Indian pharmaceutical market is witnessing strong growth and is expected to reach a CAGR of 8-9 per cent in 2026. 

The projected growth for FY 2025 also remains significant, reaching 7.5-8 per cent. This is reported by
ANI, a partner of TV BRICS.

Krishnanath Munde, associate director at India Ratings and Research, said the growth for FY 2024 was 6.5 per cent.

The 12-month sales of pharmaceuticals rose 8.1 per cent in February. Cardiology drugs were the best performers, up 10.8 per cent. They were followed by gastroenterological, neurological, and dermatological drugs.

Photo:
iStock